The mechanisms of Chansu in inducing efficient apoptosis in colon cancer cells

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Li, Chun ^a   Hashimi, Saeed M ^a   Cao, Siyu ^a   Mellick, Albert S ^a   Duan, Wei ^b   Good, David ^a,c   Wei, Ming Q ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CINOBUFAGIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER THERAPY; CELL PROLIFERATION; CHANSU; CHINESE MEDICINE; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY TEST; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84879407524     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/849054     Document Type: Article

References (43)

1. Seruga B., Ocana A., Tannock I. F., Drug resistance in metastatic castration-resistant prostate cancer. Nature Reviews Clinical Oncology 2011 8 1 12 23 2-s2.0-78650526609 10.1038/nrclinonc.2010.136
2. Lim K. H. C., Lee C. Y. J., Earnest A., Seet R. C. S., Halliwell B., Does radiotherapy increase oxidative stress? A study with nasopharyngeal cancer patients revealing anomalies in isoprostanes measurements. Free Radical Research 2010 44 9 1064 1071 2-s2.0-77956362404 10.3109/10715762.2010.499906
3. Roch-Lefèvre S., Pouzoulet F., Giraudet A. L., Voisin P., Vaurijoux A., Gruel G., Grégoire E., Buard V., Delbos M., Voisin P., Bourhis J., Roy L., Cytogenetic assessment of heterogeneous radiation doses in cancer patients treated with fractionated radiotherapy. British Journal of Radiology 2010 83 993 759 766 2-s2.0-77955989036 10.1259/bjr/21022597
4. Rizzo J. D., Brouwers M., Hurley P., Seidenfeld J., Arcasoy M. O., Spivak J. L., Bennett C. L., Bohlius J., Evanchuk D., Goode M. J., Jakubowski A. A., Regan D. H., Somerfield M. R., Schwartz C., American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood 2010 116 20 4045 4059 2-s2.0-78549286047 10.1182/blood-2010-08-300541
5. Martoni A., Marino A., Sperandi F., Giaquinta S., Di Fabio F., Melotti B., Guaraldi M., Palomba G., Preti P., Petralia A., Artioli F., Picece V., Farris A., Mantovani L., Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer. European Journal of Cancer 2005 41 1 81 92 2-s2.0-19944413630 10.1016/j.ejca.2004.08.029
6. Belani C. P., Ramalingam S., Perry M. C., LaRocca R. V., Rinaldi D., Gable P. S., Tester W. J., Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer. Journal of Clinical Oncology 2008 26 3 468 473 2-s2.0-38649124303 10.1200/JCO.2007.13.1912
7. Uddin S., Khan A. S., Al-Kuraya K. S., Developing curcumin into a viable therapeutic for lymphoma. Expert Opinion on Investigational Drugs 2009 18 1 57 67 2-s2.0-67649342560 10.1517/13543780802594593
8. Wang T. T. Y., Schoene N. W., Kim Y. S., Mizuno C. S., Rimando A. M., Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells. Molecular Nutrition and Food Research 2010 54 3 335 344 2-s2.0-77649305163 10.1002/mnfr.200900143
9. Tabata K., Yamazaki Y., Okada M., Fukumura K., Shimada A., Sun Y., Yasukawa K., Suzuki T., Diarylheptanoids derived from alpinia officinarum induce apoptosis, S-phase arrest and differentiation in human neuroblastoma cells. Anticancer Research 2009 29 12 4981 4988 2-s2.0-75149120191
10. Niu Y. P., Li L. D., Wu L. M., Beta-aescin: a potent natural inhibitor of proliferation and inducer of apoptosis in human chronic myeloid leukemia K562 cells in vitro. Leukemia and Lymphoma 2008 49 7 1384 1391 2-s2.0-47649095710 10.1080/10428190802090151
11. Hong Z., Chan K., Yeung H. W., Simultaneous determination of bufadienolides in the traditional Chinese medicine preparation, Liu-Shen-Wan, by liquid chromatography. Journal of Pharmacy and Pharmacology 1992 44 12 1023 1026 2-s2.0-0026449022
12. Enomoto A., Rho M. C., Komiyama K., Hayashi M., Inhibitory effects of bufadienolides on interleukin-6 in MH-60 cells. Journal of Natural Products 2004 67 12 2070 2072 2-s2.0-4544372141 10.1021/np049950e
13. Qin T. J., Zhao X. H., Yun J., Zhang L. X., Ruan Z. P., Pan B. R., Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma. World Journal of Gastroenterology 2008 14 33 5210 5216 2-s2.0-58149229785 10.3748/wjg.14.5210
14. Wang J., Jin Y., Xu Z., Zheng Z., Wan S., Involvement of caspase-3 activity and survivin downregulation in cinobufocini-induced apoptosis in A 549 cells. Experimental Biology and Medicine 2009 234 5 566 572 2-s2.0-66149145921 10.3181/0811-RM-326
15. Kawazoe N., Watabe M., Masuda Y., Nakajo S., Nakaya K., Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells. Oncogene 1999 18 15 2413 2421 2-s2.0-0033561622 10.1038/sj.onc.1202555
16. Ko W. S., Park T. Y., Park C., Kim Y. H., Yoon H. J., Lee S. Y., Hong S. H., Choi B. T., Lee Y. T., Choi Y. H., Induction of apoptosis by Chan Su, a traditional Chinese medicine, in human bladder carcinoma T24 cells. Oncology Reports 2005 14 2 475 480 2-s2.0-24744443929
17. Li D., Qu X., Hou K., Zhang Y., Dong Q., Teng Y., Zhang J., Liu Y., PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells. Anti-Cancer Drugs 2009 20 1 59 64 2-s2.0-57349119864 10.1097/CAD. 0b013e3283160fd6
18. Dong Y. Q., Ma W. L., Gu J. B., Zheng W. L., Effect of cinobufagin on nuclear factor-kappaB pathway in HepG2 cells. Nan Fang Yi Ke Da Xue Xue Bao 2010 30 1 137 139
19. Wang L., Wu J., Li M., Yang X. W., Cui J. R., Pilot study on the mechanisms of growth inhibitory effect of cinobufagin on HeLa cells. Zhonghua Zhong Liu Za Zhi 2005 27 12 717 720 2-s2.0-36048939728
20. Yeh J. Y., Huang W. J., Kan S. F., Wang P. S., Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate 2003 54 2 112 124 2-s2.0-0037304261 10.1002/pros.10172
21. Yu C. H., Kan S. F., Pu H. F., Chien E. J., Wang P. S., Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells. Cancer Science 2008 99 12 2467 2476 2-s2.0-57349105671 10.1111/j.1349-7006.2008.00966.x
22. Kamano Y., Kotake A., Hashima H., Inoue M., Morita H., Takeya K., Itokawa H., Nandachi N., Segawa T., Yukita A., Saitou K., Katsuyama M., Pettit G. R., Structure-cytotoxic activity relationship for the toad poison bufadienolides. Bioorganic and Medicinal Chemistry 1998 6 7 1103 1115 2-s2.0-0031718680 10.1016/S0968-0896(98)00067-4
23. Krenn L., Kopp B., Bufadienolides from animal and plant sources. Phytochemistry 1998 48 1 1 29 2-s2.0-0032076578 10.1016/S0031-9422(97)00426-3
24. Haux J., Klepp O., Spigset O., Tretli S., Digitoxin medication and cancer; case control and internal dose-response studies. BMC Cancer 2001 1 1, article 11 2-s2.0-18744401371
25. Thornberry N. A., Rano T. A., Peterson E. P., Rasper D. M., Timkey T., Garcia-Calvo M., Houtzager V. M., Nordstrom P. A., Roy S., Vaillancourt J. P., Chapman K. T., Nicholson D. W., A combinatorial approach defines specificities of members of the caspase family and granzyme B: functional relationships established for key mediators of apoptosis. Journal of Biological Chemistry 1997 272 29 17907 17911 2-s2.0-0030849093 10.1074/jbc.272.29.17907
26. Parasassi T., Brunelli R., Costa G., De Spirito M., Krasnowska E. K., Lundeberg T., Pittaluga E., Ursini F., Thiol redox transitions in cell signaling: a lesson from N-acetylcysteine. The Scientific World Journal 2010 10 1192 1202 2-s2.0-77955867229 10.1100/tsw.2010.104
27. Xu Z. W., Wang F. M., Gao M. J., Chen X. Y., Shan N. N., Cheng S. X., Mai X., Zala G. H., Hu W. L., Xu R. C., Cardiotonic steroids attenuate ERK phosphorylation and generate cell cycle arrest to block human hepatoma cell growth. Journal of Steroid Biochemistry and Molecular Biology 2011 125 3-5 181 191 2-s2.0-79954416133 10.1016/j.jsbmb.2010.12.016
28. López-Lázaro M., Pastor N., Azrak S. S., Ayuso M. J., Austin C. A., Cortés F., Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients. Journal of Natural Products 2005 68 11 1642 1645 2-s2.0-29044433675 10.1021/np050226l
29. Johansson S., Lindholm P., Gullbo J., Larsson R., Bohlin L., Claeson P., Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells. Anti-Cancer Drugs 2001 12 5 475 483 2-s2.0-0034934296 10.1097/00001813- 200106000-00009
30. +-ATPase α 3-isoform and down-regulation of the α 1-isoform in human colorectal cancer. FEBS Letters 2004 563 1-3 151 154 2-s2.0-1842737653 10.1016/S0014-5793(04)00292-3
31. Newman R. A., Yang P., Hittelman W. N., Lu T., Ho D. H., Ni D., Chan D., Vijjeswarapu M., Cartwright C., Dixon S., Felix E., Addington C., Oleandrin-mediated oxidative stress in human melanoma cells. Journal of Experimental Therapeutics and Oncology 2006 5 3 167 181 2-s2.0-33646699335
32. 2+ is required for the activation of mitochondrial calpain to release AIF during cell death. Cell Death and Differentiation 2008 15 12 1857 1864 2-s2.0-56349169766 10.1038/cdd.2008.123
33. Badugu R., Garcia M., Bondada V., Joshi A., Geddes J. W., N terminus of calpain 1 is a mitochondrial targeting sequence. Journal of Biological Chemistry 2008 283 6 3409 3417 2-s2.0-41249100763 10.1074/jbc.M706851200
34. 2+]i in rat cardiac myocytes. American Journal of Physiology 2001 281 5 H1899 H1907 2-s2.0-0035204822
35. Vandenabeele P., Galluzzi L., Vanden Berghe T., Kroemer G., Molecular mechanisms of necroptosis: an ordered cellular explosion. Nature Reviews Molecular Cell Biology 2010 11 10 700 714 2-s2.0-77957105977 10.1038/nrm2970
36. Vanlangenakker N., Vanden Berghe T., Vandenabeele P., Many stimuli pull the necrotic trigger, an overview. Cell Death & Differentiation 2012 19 1 75 86
37. Oberst A., Dillon C. P., Weinlich R., McCormick L. L., Fitzgerald P., Pop C., Hakem R., Salvesen G. S., Green D. R., Catalytic activity of the caspase-8-FLIP L complex inhibits RIPK3-dependent necrosis. Nature 2011 471 7338 363 368 2-s2.0-79952810024 10.1038/nature09852
38. Delavallée L., Cabon L., Galán-Malo P., Lorenzo H. K., Susin S. A., AIF-mediated caspase-independent necroptosis: a new chance for targeted therapeutics. IUBMB Life 2011 63 4 221 232 2-s2.0-79954520766 10.1002/iub.432
39. Metzen E., Ratcliffe P. J., HIF hydroxylation and cellular oxygen sensing. Biological Chemistry 2004 385 3-4 223 230 2-s2.0-2542450917 10.1515/BC.2004.016
40. Harris A. L., Hypoxia-a key regulatory factor in tumour growth. Nature Reviews Cancer 2002 2 1 38 47 2-s2.0-0036359548
41. Zhang H., Qian D. Z., Tan Y. S., Lee K., Gao P., Ren Y. R., Rey S., Hammers H., Chang D., Pili R., Dang C. V., Liu J. O., Semenza G. L., Digoxin and other cardiac glycosides inhibit HIF-1 α synthesis and block tumor growth. Proceedings of the National Academy of Sciences of the United States of America 2008 105 50 19579 19586 2-s2.0-58149374576 10.1073/pnas.0809763105
42. Lin J., Denmeade S., Carducci M. A., HIF-1 α and calcium signaling as targets for treatment of prostate cancer by cardiac glycosides. Current Cancer Drug Targets 2009 9 7 881 887 2-s2.0-72849153162 10.2174/ 156800909789760249
43. Richard D. E., Berra E., Gothié E., Roux D., Pouysségur J., p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-reducible factor (HIF-1 α) and enhance the transcriptional activity of HIF-1. Journal of Biological Chemistry 1999 274 46 32631 32637 2-s2.0-0032725554 10.1074/jbc.274.46.32631